CATALOGO DEI PRODOTTI DELLA RICERCA

Ciccarese, Chiara
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.380
NA - Nord America 1.083
AS - Asia 494
Continente sconosciuto - Info sul continente non disponibili 5
Totale 2.962
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.082
GB - Regno Unito 619
CN - Cina 402
SE - Svezia 170
IT - Italia 164
IE - Irlanda 145
FR - Francia 98
DE - Germania 94
FI - Finlandia 43
SG - Singapore 36
VN - Vietnam 24
UA - Ucraina 13
NL - Olanda 10
KR - Corea 9
BE - Belgio 8
AT - Austria 6
IN - India 6
EU - Europa 4
TR - Turchia 4
JP - Giappone 3
CH - Svizzera 2
GR - Grecia 2
PH - Filippine 2
PL - Polonia 2
TH - Thailandia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BD - Bangladesh 1
CA - Canada 1
CZ - Repubblica Ceca 1
HU - Ungheria 1
IL - Israele 1
JO - Giordania 1
LK - Sri Lanka 1
MK - Macedonia 1
MY - Malesia 1
RU - Federazione Russa 1
Totale 2.962
Salva come PNG Salva come JPEG
Città #
Southend 609
Chandler 300
Dublin 145
Woodbridge 105
Beijing 99
Ann Arbor 74
Ashburn 61
Houston 54
Lawrence 46
Princeton 46
Jacksonville 44
Nanjing 41
Wilmington 38
Jinan 31
Singapore 29
Shenyang 26
Verona 21
Hebei 19
New York 15
Redwood City 14
Changsha 13
Dong Ket 13
Haikou 13
Helsinki 13
Sindelfingen 13
Tianjin 13
Zhengzhou 13
Guangzhou 11
Taizhou 10
Jiaxing 9
Bologna 8
Brussels 8
Dearborn 8
Ningbo 8
Norwalk 8
Seoul 8
Fuzhou 7
Kent 7
Nanchang 7
Lanzhou 6
Milan 6
Taiyuan 6
Vienna 6
Hangzhou 5
Seattle 5
Bussolengo 4
Catanzaro 4
Fairfield 4
Groningen 4
Trento 4
Detroit 3
Los Angeles 3
Nave 3
Renton 3
Washington 3
Athens 2
Boardman 2
Büdelsdorf 2
Frankfurt am Main 2
Lancaster 2
Lausanne 2
Ludhiana 2
Novara 2
Nürnberg 2
Osio Sotto 2
Padova 2
Rome 2
Tokyo 2
Venezia 2
Volargne 2
Wuhan 2
Amman 1
Austin 1
Bakersfield 1
Bangkok 1
Cascina 1
Chaoyang 1
Chicago 1
Clearwater 1
Colombo 1
Dhaka 1
Fremont 1
Hefei 1
Kemerovo 1
Kochi 1
Lappeenranta 1
Leawood 1
Licata 1
London 1
Markham 1
Nogara 1
Ospedaletto Euganeo 1
Pavia 1
Philadelphia 1
Prague 1
Qingdao 1
Redmond 1
Reggio Nell'emilia 1
Rochester 1
Saarbrücken 1
Totale 2.137
Salva come PNG Salva come JPEG
Nome #
Acquired hemophagocytic syndrome in a patient with synovial sarcoma: a case report 111
Magnitude of PD-1, PD-L1 and T Lymphocyte Expression on Tissue from Castration-Resistant Prostate Adenocarcinoma: An Exploratory Analysis 105
The incidence and relative risk of pulmonary toxicity in patients treated with anti-PD1/PD-L1 therapy for solid tumors: a meta-analysis of current studies 99
Investigating BRCA Mutations: A Breakthrough in Precision Medicine of Castration-Resistant Prostate Cancer 96
Reprofiling Metastatic Samples for Chromosome 9p and 14q Aberrations as a Strategy to Overcome Tumor Heterogeneity in Clear-cell Renal Cell Carcinoma 95
The Tumor Entity Denominated "clear cell-papillary renal cell carcinoma" According to the WHO 2016 new Classification, have the Clinical Characters of a Renal Cell Adenoma as does Harbor a Benign Outcome 94
Prognostic Value of Beta-Tubulin-3 and c-Myc in Muscle Invasive Urothelial Carcinoma of the Bladder 90
Targeting Met and VEGFR Axis in Metastatic Castration-Resistant Prostate Cancer: 'Game Over'? 89
Wide spetcrum mutational analysis of metastatic renal cell cancer: a retrospective next generation sequencing approach 87
Immune Checkpoint Inhibitors and Prostate Cancer: A New Frontier? 83
The Cardiovascular Toxicity of Abiraterone and Enzalutamide in Prostate Cancer 83
Cathepsin K expression in castration-resistant prostate carcinoma: a therapeutical target for patients at risk for bone metastases 82
Selected news from the 2014 Genitourinary Cancers Symposium: translating novel strategies into clinical practice 78
The route to personalized medicine in bladder cancer: where do we stand? 74
Addressing the expected survival benefit for clinical trial design in metastatic castration-resistant prostate cancer: Sensitivity analysis of randomized trials 74
The development of PARP as a successful target for cancer therapy 73
AR-V7 and prostate cancer: The watershed for treatment selection? 70
Immunotherapy versus standard of care in metastatic renal cell carcinoma. A systematic review and meta-analysis 70
Metabolic alterations in renal cell carcinoma 68
New molecular targets in non clear renal cell carcinoma: An overview of ongoing clinical trials 67
Metabolic phenotype of bladder cancer 67
Renal cell carcinoma in one year: Going inside the news of 2017 - A report of the main advances in RCC cancer research 66
De novo metastatic castration sensitive prostate cancer: State of art and future perspectives 66
Comparison Between Prognostic Classifications in De Novo Metastatic Hormone Sensitive Prostate Cancer 65
Emerging concepts on drug resistance in bladder cancer: Implications for future strategies 64
Prostate cancer heterogeneity: Discovering novel molecular targets for therapy 64
2015 and human cancer: back to overall survival 61
Inside the 2015 ASCO Genitourinary Cancers Symposium 58
Acquired hemophagocytic syndrome: comment to the case report 55
Predictive role of changes in the tumor burden and International Metastatic Renal Cell Carcinoma Database Consortium class during active surveillance for metastatic renal cell carcinoma 55
Suppression of mTOR pathway in solid tumors: lessons learned from clinical experience in renal cell carcinoma and neuroendocrine tumors and new perspectives 54
Inside the 2016 American Society of Clinical Oncology Genitourinary Cancers Symposium: part 1 - kidney cancer 52
The safety and efficacy of enzalutamide in the treatment of advanced prostate cancer 51
Bladder cancer: molecular determinants of personalized therapy 50
Inside the 2016 American Society of Clinical Oncology Genitourinary Cancers Symposium: part 2 - prostate and bladder cancer 49
Cabozantinib in Advanced Renal Cell Carcinoma: Is it a METEOR? 49
Kidney cancer and 2014: is innovation really over? 46
Metabolic Alterations in Renal and Prostate Cancer 45
Emerging Immunotargets in Bladder Cancer 45
The prospect of precision therapy for renal cell carcinoma 44
Role of STAT3 pathway in genitourinary tumors 44
Investigational therapies targeting signal transducer and activator of transcription 3 for the treatment of cancer 43
Tp53 and its potential therapeutic role as a target in bladder cancer 41
Maintenance or consolidation therapy in small-cell lung cancer: an updated systematic review and meta-analysis 35
Present and future of personalized medicine in adult genitourinary tumors 30
Cabozantinib After a Previous Immune Checkpoint Inhibitor in Metastatic Renal Cell Carcinoma: A Retrospective Multi-Institutional Analysis 28
PD-L1 Expression in De Novo Metastatic Castration-sensitive Prostate Cancer 22
Revising PTEN in the Era of Immunotherapy: New Perspectives for an Old Story 6
Totale 3.043
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.616
article - articoli 10.616
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.232
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020382 59 6 2 26 59 56 60 12 20 26 16 40
2020/2021300 38 48 18 73 38 17 11 3 2 7 20 25
2021/2022282 15 66 2 32 23 8 3 21 10 8 11 83
2022/2023827 54 96 72 136 59 221 2 62 93 11 17 4
2023/2024357 13 34 25 32 75 36 10 39 5 18 60 10
2024/20251 1 0 0 0 0 0 0 0 0 0 0 0
Totale 3.043